Glisamuride

This classification denotes an anti-diabetic agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier T4C1IE36L0. European Medicines Agency schedules Glisamuride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07929MIG. Glisamuride generally arises in the molecular formula C23H31N5O4S. The term GLISAMURIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 35, no. 5 1981, list 21.) GLISAMURIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule glisamuride under HS 29350090 and SITC 51580. As of Q4 2014, GLISAMURIDE remains the US FDA Preferred Term for this commodity. Glisamuride bears US NLM identifiers UMLS ID C2348865 and NCI Concept Code C72948. SMILES: S(=O)(=O)(NC(=O)NC1CCC(CC1)C)C1CCC(CCNC(=O)N(C2NCCCC2)C)CC1.